Help planning an opioid taper before knee or hip surgery
Part of Pain clinical trials.
This study looks at a plan to safely reduce (taper) opioid pain medicines before total knee or hip replacement surgery. It may help people who are already taking opioids and are preparing for surgery in the next 1 to 2 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning your first (primary) one-sided knee or hip replacement surgery soon (within 4 to 8 weeks)
- You currently take 20 to 90 “MME” of opioid pills by mouth each day, and that dose has been the same for at least 3 months
- You can be reached by phone reliably
- You speak English
- You are not taking certain opioid types like buprenorphine, methadone, long-acting opioid pills, or opioid skin patches
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help people with long-term (chronic) pain use less opioid medicine after surgery. It may help you reduce opioid doses while still managing your pain.
This study tests whether adding a low-dose muscle relaxant (tizanidine) to your pain plan after surgery can help you safely lower your opioid use. It's for people who have been on long-term opioids and are having surgery at specific hospitals.
This trial tests if using fewer opioids after hip replacement surgery can still control pain well. It uses a specific type of hip replacement called anterior total hip arthroplasty and aims to help patients recover with less reliance on strong pain medicines.
This Phase 3 study tests an opioid-free approach to pain control for certain orthopedic (bone/joint) surgeries. The goal is to help people manage surgical pain without using opioid pain medicines.
This research study tests a combination of non-narcotic pain medicines (like Tylenol, Celebrex, and others) to see if they can control pain after hip replacement surgery while reducing the need for strong opioids. The goal is to help patients recover with fewer side effects and less risk of opioid dependence.
This study tests a decision aid to help people who have been taking opioids for chronic pain decide if and how to safely reduce their dose. It aims to support patients and doctors in making careful, personalized choices.
Hear when a new Arthritis Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.